Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitors.
RAF kinases are part of a conserved signaling pathway that impacts cell growth, differentiation, and survival, and RAF pathway dysregulation is an attractive target for therapeutic intervention. We describe two homogeneous fluorescent formats that distinguish RAF pathway inhibitors from direct RAF kinase inhibitors, using B-RAF, B-RAF V599E, and C-RAF. A Förster-resonance energy transfer (FRET) based method was used to develop RAF and MEK cascade assays as well as a direct ERK kinase assay. This method uses a peptide substrate, that is terminally labeled with a FRET-pair of fluorophores, and that is more sensitive to proteolysis relative to the phosphorylated peptide. A second time-resolved FRET-based assay using fluorescently labeled MEK substrate was used to detect direct inhibitors of RAF kinase activity. The cascade assays detect compounds that interact with activated and unactivated kinases within the recapitulated RAF pathway, and the direct assays isolate the point of action for an inhibitor.
Kupcho
Kevin R
KR
Invitrogen Corporation, 501 Charmany Drive, Madison, WI 53719, USA.
Bruinsma
Rica
R
Hallis
Tina M
TM
Lasky
David A
DA
Somberg
Richard L
RL
Turek-Etienne
Tammy
T
Vogel
Kurt W
KW
Huwiler
Kristin G
KG